The Dilemmas of Price Control in the Pharmacy Industry

Well, I don't have to tell you that it is one of the most frustrating things to have to deal with as a pharmacist, as a consumer, as a citizen and as a customer-- price gouging.

You may have already heard about 'Martin Shkreli the pharmaceutical executive who jacked up the price of a drug (raised the price of drug Daraprim from $13.50 to $750 per pill) mainly used by cancer and HIV-AIDS patients by about 8 gazillion percent, is part of a criminal investigation involving a company he founded, according to documents on file with the Securities and Exchange Commission.'*

It's been a long battle trying to be a buyer for drugs as a pharmacist to make sure that my customers can afford the medications they need but it's another thing when it is abused by someone like him and now has put every other company under the microscope for this act.

I'm personally hoping that the cost of medications AND services will be reevaluated for the benefit of the customer as these are dubious times and we are thrown up against the wall wondering who we can trust.



*excerpt taken from http://www.huffingtonpost.com/entry/martin-shkreli-sec-investigation_5601a3c4e4b08820d91a6b6f